A COST MINIMISATION ANALYSIS OF CLADRIBINE TABLETS VERSUS ALTERNATIVE HIGH EFFICACY TREATMENTS FOR RELAPSING MULTIPLE SCLEROSIS (RMS) IN THE UNIED KINGDOM.

Authors
Category Systematic review
JournalValue in Health
Year 2018
This article has no abstract
Epistemonikos ID: 9fa6907d311fff8c604b28e46d5cf316b89ace40
First added on: Feb 09, 2025